Infusystem Hld Stock Price, News & Analysis

InfuSystem Holdings, Inc. (NYSE American: INFU) will release its fourth quarter and full year 2020 financial results on March 17, 2021, before market opening. The company provides outpatient care services for durable medical equipment. Following the results announcement, a conference call will be held at 9:00 a.m. Eastern Time to discuss the financials. Investors can participate by calling (833) 366-1127 or through a live webcast on the company’s website. A replay will be available for 90 days.

InfuSystem Holdings announces the promotion of Carrie Lachance to President, adding to her current role as Chief Operating Officer. CEO Richard DiIorio praised her leadership in patient and customer care. This leadership change aims to strengthen the company’s growth strategy and enhance its two operational platforms: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME). Lachance, with over 20 years of healthcare experience, focuses on scaling new therapies and products.

InfuSystem Holdings, Inc. (NYSE American: INFU) announced a new $75 million revolving credit facility with JPMorgan Chase Bank, replacing a $49 million facility. Effective February 5, 2021, this facility enhances liquidity and financial flexibility, allowing the company to capitalize on growth opportunities in Integrated Therapy Services and Durable Medical Equipment Services. With this facility, InfuSystem's liquidity increases to over $45 million from approximately $20 million previously. The facility features a five-year term and an interest rate tied to the company's Total Leverage Ratio.

InfuSystem Holdings, Inc. (NYSE American: INFU) has announced the acquisition of FilAMed, a biomedical services company based in Bakersfield, CA. Although the terms of the transaction were not disclosed, CEO Richard DiIorio emphasized the strategic importance of this acquisition in expanding InfuSystem's capabilities within its Durable Medical Equipment Services (DME) platform. The acquisition aims to enhance service offerings such as compression devices and patient monitors, while providing a broader range of services and facilitating entry into the acute care market.

InfuSystem Holdings, Inc. (NYSE: INFU) has announced its financial guidance for 2021, projecting net revenues of $107 million to $110 million, Adjusted EBITDA of $29 million to $30 million, and operating cash flow of $21 million to $23 million. Management anticipates strong growth driven by its Integrated Therapy Services (ITS) Segment, particularly in Pain Management and Negative Pressure Wound Therapy. Despite expecting tailwinds from COVID-19, they remain cautious about potential impacts on operations.

InfuSystem Holdings, Inc. (NYSE American: INFU) will be participating in the 13th Annual LD Micro Main Event on December 15, 2020, at 3:00 p.m. ET. The presentation will be conducted virtually by CEO Rich DiIorio and CFO Barry Steele.

InfuSystem is a prominent health care service provider specializing in outpatient care for durable medical equipment. The company operates through two platforms: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services), servicing areas including Oncology, Pain Management, and Wound Therapy.

InfuSystem Holdings, Inc. (NYSE American: INFU) will announce its full year 2021 annual financial guidance on December 15, 2020, prior to market opening. A conference call for investors will occur at 9:00 a.m. Eastern Time on the same day to discuss the guidance and business developments. Interested participants can join via phone or through a live webcast on the company’s website. InfuSystem specializes in providing outpatient care solutions for manufacturers and healthcare providers under two platforms: Integrated Therapy Services and Durable Medical Equipment Services.

InfuSystem Holdings, a prominent health care service provider, announced that CEO Rich DiIorio and CFO Barry Steele will present at key investor conferences on November 17 and 19, 2020. The conferences include the Craig-Hallum Capital Group 11th Annual Alpha Select Conference and the Sidoti & Company Virtual Microcap Conference. A presentation at the latter is scheduled for 2:30 p.m. ET, with a webcast available on InfuSystem's investor relations website. The company focuses on outpatient care for durable medical equipment, serving sectors like oncology and pain management.

InfuSystem Holdings reported robust Q3 2020 financial results, with net revenues of $25.1 million, representing a 17% increase compared to the previous year. Net income surged by 159% to $2.9 million, while Adjusted EBITDA rose 46% to $7.5 million. The company has raised its full-year guidance to estimated revenues of $96 million - $97 million and Adjusted EBITDA of $26 million - $27 million. Strong performance was driven by increased demand in oncology and a growing market for infusion pumps due to COVID-19, leading to improved operating cash flow and profitability.